These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34387243)

  • 1. Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept.
    Noble J; Langello A; Bouchut W; Lupo J; Lombardo D; Rostaing L
    Transplantation; 2021 Nov; 105(11):e259-e260. PubMed ID: 34387243
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-SARS-CoV-2 T-cell Responses After mRNA Vaccination in Belatacept-treated Renal Transplant Patients.
    Dolff S; Korth J; Jahn M; Kribben A; Witzke O; Wilde B
    Transplantation; 2021 Sep; 105(9):e99. PubMed ID: 33966023
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.
    Mitchell J; Kim J; Alejo JL; Chiang TP; Karaba AH; Blankson JN; Aytenfisu TY; Chang A; Abedon AT; Avery RK; Tobian AA; Massie AB; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 May; 106(5):e264-e265. PubMed ID: 35289776
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept.
    Ou MT; Boyarsky BJ; Chiang TPY; Bae S; Werbel WA; Avery RK; Tobian AAR; Massie AB; Segev DL; Garonzik-Wang JM
    Transplantation; 2021 Sep; 105(9):2119-2123. PubMed ID: 34028386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of SARS-CoV-2 infection in kidney transplant recipients on belatacept: a single-center experience.
    Feller F; Azar MM; Marvin J; Cohen E; Virmani S; Malinis M
    Transpl Infect Dis; 2024 Apr; 26(2):e14253. PubMed ID: 38351494
    [No Abstract]   [Full Text] [Related]  

  • 6. Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept.
    Chavarot N; Ouedrani A; Marion O; Leruez-Ville M; Vilain E; Baaziz M; Del Bello A; Burger C; Sberro-Soussan R; Martinez F; Chatenoud L; Abravanel F; Anglicheau D; Izopet J; Couat C; Zuber J; Legendre C; Lanternier F; Kamar N; Scemla A
    Transplantation; 2021 Sep; 105(9):e94-e95. PubMed ID: 33831941
    [No Abstract]   [Full Text] [Related]  

  • 7. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.
    Chavarot N; Morel A; Leruez-Ville M; Vilain E; Divard G; Burger C; Serris A; Sberro-Soussan R; Martinez F; Amrouche L; Bererhi L; Lanternier F; Legendre C; Zuber J; Anglicheau D; Scemla A
    Am J Transplant; 2021 Dec; 21(12):4043-4051. PubMed ID: 34431207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.
    Tsalouchos A; Rossolini GM; Maggi L; Mazzoni A; Annunziato F; Dattolo PC
    Transpl Infect Dis; 2021 Aug; 23(4):e13649. PubMed ID: 34032340
    [No Abstract]   [Full Text] [Related]  

  • 9. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1498-1500. PubMed ID: 33887315
    [No Abstract]   [Full Text] [Related]  

  • 10. Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.
    López V; Polo C; Schuldt R; Vázquez T; Gutiérrez-Vílchez E; Moliz C; Hernández D
    Transplant Proc; 2022 Nov; 54(9):2454-2456. PubMed ID: 36273957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674
    [No Abstract]   [Full Text] [Related]  

  • 12. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
    Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
    Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept.
    Pernin V; Meneghini M; Torija A; Jouve T; Del Bello A; Sanz-Muñoz I; Eiros JM; Donadeu L; Polo C; Morandeira F; Navarro S; Masuet C; Favà A; LeQuintrec M; Kamar N; Crespo E; Bestard O
    Front Immunol; 2022; 13():918887. PubMed ID: 35967428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.
    Firket L; Descy J; Seidel L; Bonvoisin C; Bouquegneau A; Grosch S; Jouret F; Weekers L
    Am J Transplant; 2021 Nov; 21(11):3806-3807. PubMed ID: 34153162
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection against SARS-CoV-2 Variants with COVID-19 Vaccination in Kidney Transplant Recipients.
    Bertrand D; Candon S
    Clin J Am Soc Nephrol; 2022 Jan; 17(1):3-5. PubMed ID: 34937770
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort Study.
    Matsunami M; Suzuki T; Sugihara S; Toishi T; Nagaoka K; Fukuda J; Ohara M; Takanashi Y; Ochi A; Yashima J; Kuji H; Matsue K
    Transplant Proc; 2022; 54(6):1483-1488. PubMed ID: 35868872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Due to COVID-19 in Renal Transplant Recipients, Related to Variants of SARS-CoV-2 and Vaccination in Mexico.
    Rivera JCHH; Mendoza MS; Covarrubias LG; Ramírez ALQ; Reyes LC; Hernández MB; Martínez JR; Contla YP; Durán JMV; Rivas AT; Flores SLR; Murillo WAQ; Sierra JRP
    Transplant Proc; 2022; 54(6):1434-1438. PubMed ID: 35931470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.